arrow
P

Pasqualina D'Ursi

Institute for Biomedical Technologies
H指数:18
被引数:844

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ligand-specific binding kinetics and molecular interactions of clinically used PSMA diagnostic radiopharmaceuticals: an integrated in silico and in vitro study

临床常用PSMA诊断放射性药物的配体特异性结合动力学与分子相互作用:一项整合计算机模拟和体外研究的综合研究

2026-08-290
OA
Fei-Yan-Qing-Hua decoction inhibits influenza viral replication by enhancing NK cell maturation and activation through the upregulation of JAK/STAT/T-bet signalling axis

飞艳清化汤通过上调JAK/STAT/T-bet信号轴增强NK细胞成熟和活化来抑制流感病毒复制

2026-04-160
OAAI
An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: A therapy oriented proof of concept based on UV-C irradiation of SARS-CoV-2 spike protein
2023-08-012
OAAI
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host
2022-05-2123
OAAI
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin (Aug, 10.1038/s41417-021-00379-5, 2021)

胆酸衍生物UniPR1331通过阻断除Eph/ephrin之外的VEGF/VEGFR2来损害肿瘤血管生成 (8月,10.1038/s41417-021-00379-5,2021)

2021-09-300
OAAI
Exploitation of a novel biosensor based on the full-length human F508de1-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue
2019-12-0110
PREAI